Bayer’s CEO cut manager ranks by 70%. Now comes the hard part

Bayer has undertaken a sweeping internal reorganization under CEO Bill Anderson, reducing management ranks and replacing traditional corporate processes with smaller teams operating on shorter planning cycles. The changes have reshaped how the 163-year-old health science company is structured. The next question is whether that streamlined model can support renewed growth.

A sharp reduction in managers

Anderson has reduced the number of managers at Bayer from about 16,000 to 4,500. The cuts were made across a company with roughly 88,000 employees, making the change a significant shift in its organizational design.

The restructuring has also moved Bayer away from a conventional hierarchy and annual budgeting system. In their place are 5,000 small teams working in 90-day cycles. That approach puts the emphasis on shorter operating periods and a more distributed team structure.

The challenge after restructuring

Flattening and streamlining a large company can change its internal processes, but it does not by itself answer how the business will expand. For Bayer, the focus now turns to what comes after the organizational overhaul.

That question was put to Anderson following the company’s transformation. The available account establishes the scale of the restructuring but does not provide his answer on the next steps for growth. Bayer’s future direction therefore remains tied to how its new team-based model is used after the management reset.

What comes next

Bayer’s reorganization has created a markedly different operating structure. Its next test will be moving from simplification and transformation toward growth, while working through a system built around small teams and 90-day cycles.